USNA Insider Trading

Insider Ownership Percentage: 0.33%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $2,295,507.57

USANA Health Sciences Insider Trading History Chart

This chart shows the insider buying and selling history at USANA Health Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$1M$0$1MTotal Insider BuyingTotal Insider Selling

USANA Health Sciences Share Price & Price History

Current Price: $25.39
Price Change: Price Increase of +1.18 (4.87%)
As of 04/9/2025 04:11 PM ET

This chart shows the closing price history over time for USNA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$24.32Closing price on 04/08/25:

SEC Filings (Institutional Ownership Changes) for USANA Health Sciences (NYSE:USNA)

54.25% of USANA Health Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at USNA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$272kbought$332ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$10M-$5M$0$5M$10MTotal InflowsTotal Outflows
USANA Health Sciences logo
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Read More on USANA Health Sciences

Today's Range

Now: $25.39
Low: $24.01
High: $26.44

50 Day Range

MA: $29.77
Low: $24.32
High: $34.96

52 Week Range

Now: $25.39
Low: $23.51
High: $49.78

Volume

124,841 shs

Average Volume

114,256 shs

Market Capitalization

$480.00 million

P/E Ratio

9.01

Dividend Yield

N/A

Beta

1

Who are the company insiders with the largest holdings of USANA Health Sciences?

USANA Health Sciences' top insider shareholders include:
  1. Myron W Wentz (Major Shareholder)
  2. Jim Brown (CEO)
  3. David Mulham Mulham (Insider)
  4. Kevin Guest (Chairman)
  5. Paul A Jones (Insider)
  6. John Turman Fleming (Director)
  7. Peggie Pelosi (Director)
  8. Frederic J Winssinger (Director)
  9. Xia Ding (Director)
  10. Daniel A Macuga (Insider)
  11. Gilbert A Fuller (Director)
  12. Brent Neidig (Insider)
  13. Daniel A Macuga (Insider)
  14. G Doug Iiekking (CFO)
  15. Gilbert A Fuller (Director)
  16. Jim Brown (President)
  17. Joshua Foukas (Insider)
  18. Paul A Jones (Insider)
  19. Robert A Sinnott (Insider)
  20. Walter Noot (COO)
Learn More about top insider investors at USANA Health Sciences.

Who are the major institutional investors of USANA Health Sciences?

USANA Health Sciences' top institutional shareholders include:
  1. Rhumbline Advisers — 0.19%
  2. GAMMA Investing LLC — 0.04%
  3. Parallel Advisors LLC — 0.01%
  4. Versant Capital Management Inc — 0.01%
Learn More about top institutional investors of USANA Health Sciences stock.

Which major investors are selling USANA Health Sciences stock?

During the previous quarter, USNA stock was sold by these institutional investors:
  1. Rhumbline Advisers
In the last year, company insiders that have sold USANA Health Sciences company stock include:
  1. Myron W Wentz (Major Shareholder)
  2. Jim Brown (CEO)
  3. David Mulham Mulham (Insider)
  4. Kevin Guest (Chairman)
  5. Paul A Jones (Insider)
  6. John Turman Fleming (Director)
  7. Peggie Pelosi (Director)
  8. Frederic J Winssinger (Director)
  9. Xia Ding (Director)
  10. Daniel A Macuga (Insider)
  11. Gilbert A Fuller (Director)
Learn More investors selling USANA Health Sciences stock.

Which major investors are buying USANA Health Sciences stock?

During the previous quarter, USNA stock was purchased by institutional investors including:
  1. GAMMA Investing LLC
  2. Parallel Advisors LLC
  3. Versant Capital Management Inc